KR7214450009
KR7214450009
PharmaResearch
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 3.14T EUR | 3.81T EUR | 3.25T EUR | 4.19T EUR |
Enterprise Value | 2.8T EUR | 3.6T EUR | 3.06T EUR | 4.02T EUR |
Valuation Multiples | ||||
Trailing P/E | -- | 20.51x | 18.42x | 32.47x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 5.21x | 6.31x | 5.75x | 9.98x |
Price to Book | -- | 5.05x | 4.67x | 6.07x |
EV/Revenue | 4.65x | 5.97x | 5.41x | 9.59x |
EV/EBITDA | 11.1x | 13.35x | 11.86x | 21.47x |
Price to FCF (P/FCF) | 35.66x | 27.95x | 21.95x | 33.28x |
EV/FCF | 31.81x | 26.43x | 20.63x | 31.96x |
FCF Yield | 2.8% | 3.58% | 4.56% | 3.01% |